Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LY96 | Q9Y6Y9 | 2/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.71 |
| ▸ | LMNA | P02545 | 4/20 | 0.71 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.68 |
| ▸ | MAPT | P10636 | 6/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.66 |
| ▸ | NPC1 | O15118 | 3/20 | 0.66 |
| ▸ | RAB9A | P51151 | 2/20 | 0.66 |
| ▸ | ATM | Q13315 | 2/20 | 0.66 |
| ▸ | XBP1 | P17861 | 2/20 | 0.66 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.66 |
| ▸ | PKM | P14618 | 1/20 | 0.66 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.66 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.66 |
| ▸ | MEN1 | O00255 | 4/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.64 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.61 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25842377 | 0.91 | LY96 (0.82) | LY96SMN1; SMN2LMNAHSD17B3MAPT | |
| SCHEMBL14597262 | 0.84 | LY96 (0.72) | LY96SMN1; SMN2LMNAHSD17B3MAPT | |
| SCHEMBL17899535 | 0.84 | LY96 (0.72) | LY96SMN1; SMN2LMNAHSD17B3MAPT | |
| SCHEMBL22822872 | 0.83 | MAPT (0.72) | LY96SMN1; SMN2LMNAMAPTALDH1A1 | |
| SCHEMBL17899519 | 0.81 | HSD17B3 (1.00) | LY96SMN1; SMN2LMNAHSD17B3MAPT | |
| SCHEMBL22823103 | 0.81 | SMN1; SMN2 (0.76) | LY96SMN1; SMN2LMNAHSD17B3MAPT | |
| SCHEMBL22462348 | 0.80 | LY96 (0.67) | LY96SMN1; SMN2LMNAHSD17B3MAPT | |
| SCHEMBL22462349 | 0.80 | LY96 (0.67) | LY96SMN1; SMN2LMNAHSD17B3MAPT | |
| SCHEMBL22822756 | 0.80 | LY96 (0.67) | LY96SMN1; SMN2LMNAHSD17B3MAPT | |
| SCHEMBL31686199 | 0.80 | LY96 (0.67) | LY96SMN1; SMN2LMNAMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025106009-A1 | SYNCHRONIZATION BETWEEN A COMMUNICATION DEVICE AND A NETWORK UPON COMMUNICATION DEVICE AUTONOMOUS RELEASE OF A QUALITY OF EXPERIENCE CONFIGURATION | TELEFONAKTIEBOLAGET LM ERICSSON (PUBL) (SE) | 2025-05-22 | — | — | WO | disclosed |
| US-20250060518-A1 | NANOPARTICLE FILM PATTERNING METHOD, METHOD FOR PRODUCING LIGHT-EMITTING ELEMENT, METHOD FOR PRODUCING DISPLAY DEVICE, AND LIGHT-EMITTING ELEMENT | SHARP KABUSHIKI KAISHA (JP) | 2025-02-20 | — | — | US | disclosed |
| US-12197062-B2 | Liquid crystal composition for light-scattering liquid crystal device, light-scattering liquid crystal device, and smart window | DIC CORPORATION (JP) | 2025-01-14 | — | — | US | disclosed |
| CN-117581636-A | Nanoparticle film patterning method, light-emitting element manufacturing method, display device manufacturing method, and light-emitting element | 夏普株式会社 | 2024-02-20 | — | — | CN | disclosed |
| US-20230357200-A1 | SMALL MOLECULE STIMULATORS OF STEROID RECEPTOR COACTIVATOR-3 AND METHODS OF THEIR USE AS CARDIOPROTECTIVE AND/OR VASCULAR REGENERATIVE AGENTS | BAYLOR COLLEGE OF MEDICINE (US) | 2023-11-09 | — | — | US | disclosed |
| CN-219802310-U | Sensor piezoelectric signal detection circuit | 北京钛方科技有限责任公司 | 2023-10-03 | — | — | CN | disclosed |
| US-20230287272-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DEVICE | DIC CORPORATION (JP) | 2023-09-14 | — | — | US | disclosed |
| US-11739270-B2 | Polymerizable compound as well as liquid crystal composition and liquid crystal display device each including polymerizable compound | DIC CORPORATION (JP) | 2023-08-29 | — | — | US | disclosed |
| EP-3823301-B1 | SOUND FIELD FORMING APPARATUS AND METHOD AND PROGRAM | SONY GROUP CORP (JP) | 2023-08-23 | — | — | EP | disclosed |
| US-11708350-B2 | Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or vascular regenerative agents | BAYLOR COLLEGE OF MEDICINE (US) | 2023-07-25 | — | — | US | disclosed |
| US-11326103-B2 | Liquid crystal display device | DIC CORPORATION (JP) | 2022-05-10 | — | — | US | disclosed |
| US-20220128867-A1 | SUBSTRATE AND LIQUID CRYSTAL DISPLAY DEVICE | DIC CORPORATION (JP) | 2022-04-28 | — | — | US | disclosed |
| US-11312676-B2 | Small molecule stimulators of steroid receptor coactivator proteins and their use in the treatment of cancer | BAYLOR COLLEGE OF MEDICINE (US) | 2022-04-26 | — | — | US | disclosed |
| US-11312906-B2 | Polymerizable monomer, liquid crystal composition using polymerizable monomer, and liquid crystal display device | DIC CORPORATION (JP) | 2022-04-26 | — | — | US | disclosed |
| US-20220057672-A1 | LIQUID CRYSTAL COMPOSITION FOR LIGHT-SCATTERING LIQUID CRYSTAL DEVICE, LIGHT-SCATTERING LIQUID CRYSTAL DEVICE, AND SMART WINDOW | DIC CORPORATION (JP) | 2022-02-24 | — | — | US | disclosed |
| US-20210115017-A1 | SMALL MOLECULE STIMULATORS OF STEROID RECEPTOR COACTIVATOR-3 AND METHODS OF THEIR USE AS CARDIOPROTECTIVE AND/OR VASCULAR REGENERATIVE AGENTS | BAYLOR COLLEGE OF MEDICINE (US) | 2021-04-22 | — | — | US | disclosed |
| US-10875841-B2 | Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or vascular regenerative agents | BAYLOR COLLEGE OF MEDICINE (US) | 2020-12-29 | — | — | US | disclosed |
| US-20200399220-A1 | 3,5-DIARYLIDENYL-N-SUBSTITUTED-PIPERID-4-ONE-DERIVED INHIBITORS OF STAT3 PATHWAY ACTIVITY AND USES THEREOF | KIAKOS KONSTANTINOS (AT) | 2020-12-24 | — | — | US | disclosed |
| US-20200071300-A1 | Small Molecule Stimulators of Steroid Receptor Coactivator-3 and Methods of Their Use as Cardioprotective and/or Vascular Regenerative Agents | BAYLOR COLLEGE OF MEDICINE (US) | 2020-03-05 | — | — | US | disclosed |
| WO-2016109470-A1 | SMALL MOLECULE STIMULATORS OF STEROID RECEPTOR COACTIVATOR PROTEINS AND THEIR USE IN THE TREATMENT OF CANCER | BAYLOR COLLEGE OF MEDICINE (US) | 2016-07-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11739270-B2 | Polymerizable compound as well as liquid crystal composition and liquid crystal display device each including polymerizable compound | OCIAD2, PKN2, SKP1 | LY96 1665/4885SMN1; SMN2 3918/4885LMNA 3654/4885 |
| US-20200071300-A1 | Small Molecule Stimulators of Steroid Receptor Coactivator-3 and Methods of Their Use as Cardioprotective and/or Vascular Regenerative Agents | NCOA3, FABP3, NCOA1 | LY96 1393/4885SMN1; SMN2 3684/4885LMNA 2223/4885 |
| US-11312676-B2 | Small molecule stimulators of steroid receptor coactivator proteins and their use in the treatment of cancer | NCOA2, NCOA1, NCOA3 | LY96 1243/4885SMN1; SMN2 4722/4885LMNA 4287/4885 |
| US-20210115017-A1 | SMALL MOLECULE STIMULATORS OF STEROID RECEPTOR COACTIVATOR-3 AND METHODS OF THEIR USE AS CARDIOPROTECTIVE AND/OR VASCULAR REGENERATIVE AGENTS | NCOA3, FABP3, NCOA1 | LY96 1393/4885SMN1; SMN2 3684/4885LMNA 2223/4885 |
| US-11708350-B2 | Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or vascular regenerative agents | NCOA3, FABP3, NCOA1 | LY96 1393/4885SMN1; SMN2 3684/4885LMNA 2223/4885 |
| US-10875841-B2 | Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or vascular regenerative agents | NCOA3, FABP3, NCOA1 | LY96 1393/4885SMN1; SMN2 3684/4885LMNA 2223/4885 |
| US-20200399220-A1 | 3,5-DIARYLIDENYL-N-SUBSTITUTED-PIPERID-4-ONE-DERIVED INHIBITORS OF STAT3 PATHWAY ACTIVITY AND USES THEREOF | STAT3, JAK2, STAT6 | LY96 1163/4885SMN1; SMN2 4073/4885LMNA 3396/4885 |
| US-20230357200-A1 | SMALL MOLECULE STIMULATORS OF STEROID RECEPTOR COACTIVATOR-3 AND METHODS OF THEIR USE AS CARDIOPROTECTIVE AND/OR VASCULAR REGENERATIVE AGENTS | NCOA3, FABP3, NCOA1 | LY96 1393/4885SMN1; SMN2 3684/4885LMNA 2223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.